Pharmakologie der ADP-Rezeptoren auf humanen Thrombozyten

46. Garcia, A., A.B. Galler, U. Walter, M. Reinhard, and A. Simm. 2002. Increased Spreading, Rac/p21activated
Kinase (PAK) Activity, and Compromised Cell Motility in Cells Deficient in
Vasodilator-stimulated Phosphoprotein (VASP). J Biol Chem 277:45604-45610.
47. Gawaz, M. 1999. Das Blutplaettchen. Georg Thieme Verlag
48. Geiger, J., J. Brich, L. Honig, M. Eigenthaler, P. Schanzenbacher, J.M. Herbert, and U. Walter. 1999.
Specific impairment of human platelet P2Y(AC) ADP receptor-mediated signaling by the
antiplatelet drug clopidogrel. Arterioscler Thromb Vasc Biol 19:2007-2011.
49. Geiger, J., L. Honig, P. Schanzenbacher, and U. Walter. 1998. Ligand specificity and ticlopidine
effects distinguish three human platelet ADP receptors. Eur J Pharmacol 351:235-246.
50. Geiger, J., C. Nolte, E. Butt, S.O. Sage, and U. Walter. 1992. Role of cGMP and cGMP-dependent
protein kinase in nitrovasodilator inhibition of agonist-evoked calcium elevation in human
platelets. Proc Natl Acad Sci U S A 89:1031-1035.
51. Geiger, J., C. Nolte, and U. Walter. 1994. Regulation of calcium mobilization and entry in human
platelets by endothelium-derived factors. Am J Physiol 267:C236-C244
52. Geiger, J. and U. Walter. 1993. Properties and regulation of human platelet cation channels. EXS
66:281-288.
53. Gent, M., J.A. Blakely, J.D. Easton, D.J. Ellis, V.C. Hachinski, J.W. Harbison, E. Panak, R.S. Roberts,
J. Sicurella, and A.G. Turpie. 1989. The Canadian American Ticlopidine Study (CATS) in
thromboembolic stroke. Lancet 1:1215-1220.
54. Greco, N.J., G. Tonon, W. Chen, X. Luo, R. Dalal, and G.A. Jamieson. 2001. Novel structurally
altered P(2X1) receptor is preferentially activated by adenosine diphosphate in platelets and
megakaryocytic cells. Blood 98:100-107.
55. Grundmann, K., K. Jaschonek, B. Kleine, J. Dichgans, and H. Topka. 2003. Aspirin non-responder
status in patients with recurrent cerebral ischemic attacks. J Neurol 250:63-66.
56. Gurbel, P.A., C.C. Cummings, C.R. Bell, A.B. Alford, A.F. Meister, and V.L. Serebruany. 2003. Onset
and extent of platelet inhibition by clopidogrel loading in patients undergoing elective
coronary stenting: the Plavix Reduction Of New Thrombus Occurrence (PRONTO) trial. Am
Heart J 145:239-247.
57. Habib, A., G.A. FitzGerald, and J. Maclouf. 1999. Phosphorylation of the thromboxane receptor alpha,
the predominant isoform expressed in human platelets. J Biol Chem 274:2645-2651.
58. Halbrugge, M., C. Friedrich, M. Eigenthaler, P. Schanzenbacher, and U. Walter. 1990. Stoichiometric
and reversible phosphorylation of a 46-kDa protein in human platelets in response to cGMP-
and cAMP-elevating vasodilators. J Biol Chem 265:3088-3093.
59. Halbrugge, M. and U. Walter. 1989. Purification of a vasodilator-regulated phosphoprotein from
human platelets. Eur J Biochem 185:41-50.
60. Hall, R.A., L.S. Ostedgaard, R.T. Premont, J.T. Blitzer, N. Rahman, M.J. Welsh, and R.J. Lefkowitz.
1998. A C-terminal motif found in the beta2-adrenergic receptor, P2Y1 receptor and cystic
fibrosis transmembrane conductance regulator determines binding to the Na+/H+ exchanger
regulatory factor family of PDZ proteins. Proc Natl Acad Sci U S A 95:8496-8501.
61. Harbeck, B., S. Huttelmaier, K. Schluter, B.M. Jockusch, and S. Illenberger. 2000. Phosphorylation of
the vasodilator-stimulated phosphoprotein regulates its interaction with actin. J Biol Chem
275:30817-30825.
107